2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
May 15, 2024
Video
Debu Tripathy, MD, discusses the current state of HER2-positive breast cancer treatment.
May 13, 2024
Video
Debu Tripathy, MD, discusses real-world strategies for CDK4/6 inhibitor use and the importance of HER2 testing in HER2-positive metastatic breast cancer.
May 10, 2024
Video
Ramez Kouzy, MD, discusses efforts to improve knowledge of the use of AI in radiation oncology through the creation of an online repository.
May 10, 2024
Video
Ramez Kouzy, MD, discusses efforts to improve knowledge of the use of AI in radiation oncology through the creation of an online repository.
May 09, 2024
Video
James Ignatz-Hoover, MD, PhD, discusses the current arsenal of FDA-approved bispecific antibodies in multiple myeloma.
May 09, 2024
Article
Naval G. Daver, MD, highlights ongoing research efforts in relapsed/refractory AML, including combination regimens and pathways targeted by novel agents.
May 09, 2024
Video
The panel concludes with perspectives on the future of treatment for patients with colorectal cancer, including unmet needs in the disease space.
May 02, 2024
Video
Núria Agustí Garcia, MD, discusses the mapping of sentinel lymph nodes in early-stage ovarian cancer.
May 02, 2024
Video
Clinical insights on the roles of various members within a multidisciplinary team involved in the care of patients with colorectal cancer.
May 02, 2024
Video
Experts on colorectal cancer discuss the treatment decision-making process, highlighting the safety profiles of fruquintinib and regorafenib.
May 01, 2024
Video
Naval G. Daver, MD, discusses the future of targeted therapy development for patients with acute myeloid leukemia.
May 01, 2024
Video
Elias Jabbour, MD, discusses outcomes from the phase 3 PhALLCON trial in patients with Ph-positive acute lymphoblastic leukemia.
May 01, 2024
Video
Debu Tripathy, MD, discusses the current state of the HER2-positive breast cancer treatment paradigm.
April 30, 2024
Video
Scott Kopetz, MD, PhD, FACP, discusses the potential FDA approval of adagrasib in combination with cetuximab in KRAS G12C-mutatated colorectal cancer.
April 29, 2024
Article
Samer A. Srour, MB ChB, MS, explains the significance of early safety and efficacy data with CTX130 in CD70-expressing clear cell renal cell carcinoma.
April 26, 2024
Video
Scott Kopetz, MD, PhD, FACP, discusses using adagrasib plus cetuximab in patients with metastatic colorectal cancer harboring KRAS G12C mutations.
April 24, 2024
Video
James Ignatz-Hoover, MD, PhD, discusses the implications of utilizing blinatumomab to treat acute lymphoblastic leukemia.
April 23, 2024
Video
Eric K. Singhe, MD, of The University of Texas MD Anderson Cancer Center, discusses the journey of non–smell cell lung cancer treatment through mentorship, advocacy, and more.
April 23, 2024
Video
Samer A. Srour, MB ChB, MS, discusses the investigation of the allogeneic CAR T-cell therapy CTX131 in advanced clear cell renal cell carcinoma.
April 22, 2024
Article
Debu Tripathy, MD, highlights the potential role and significance of vepdegestrant in pretreated ER-positive/HER2-negative breast cancer.